down arrow

Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
  • View on NSE | View on BSE
INR
850.00
12.15 (1.45%)
BSENSE

Sep 24, 10:43 AM

BSE+NSE Vol: 2.89 lacs

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
735.20
739.10
647.30
1,363.00
1,328.90
1,221.00
474.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
735.20
739.10
647.30
1,363.00
1,328.90
1,221.00
474.80
Raw Material Cost
157.80
102.80
135.20
174.90
180.60
169.00
72.70
Purchase of Finished goods
27.80
37.50
55.80
72.60
37.30
40.80
39.10
(Increase) / Decrease In Stocks
-38.10
14.40
-57.90
-77.80
15.10
39.40
-29.00
Employee Cost
179.30
158.50
159.40
200.30
169.00
159.40
141.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
221.90
298.30
196.10
413.80
355.90
264.30
211.60
Total Expenditure (Excl Depreciation)
548.70
611.50
488.60
783.80
757.90
672.90
436.00
Operating Profit (PBDIT) excl Other Income
186.50
127.60
158.70
579.20
571.00
548.10
38.80
Other Income
59.20
77.80
58.10
100.00
61.70
66.30
176.30
Operating Profit (PBDIT)
245.70
205.40
216.80
679.20
632.70
614.40
215.10
Interest
13.00
10.90
9.50
13.10
3.20
10.20
4.40
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
232.70
194.50
207.30
666.10
629.50
604.20
210.70
Depreciation
47.10
50.40
46.20
52.40
57.60
98.30
47.00
Profit Before Tax
185.60
144.10
161.10
613.70
571.90
505.90
163.70
Tax
63.40
-89.20
20.70
95.80
91.60
99.90
31.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
122.20
233.30
140.40
517.90
480.30
406.00
132.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
122.20
233.30
140.40
517.90
480.30
406.00
132.40
Share in Profit of Associates
84.30
35.70
10.90
0.00
0.00
0.00
0.00
Minority Interest
0.00
1.10
-0.20
-0.50
-0.40
-0.60
-0.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
206.50
267.90
151.50
518.40
480.70
406.60
133.00
Equity Capital
35.80
35.80
35.80
35.80
35.80
35.80
35.80
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
11.54
14.97
8.46
28.96
26.85
22.72
7.43
Diluted Earnings per share
11.53
14.96
8.46
28.94
26.84
22.7
7.43
Operating Profit Margin (Excl OI)
25.37%
17.26%
24.52%
42.49%
42.97%
44.89%
8.17%
Gross Profit Margin
31.65%
26.32%
32.03%
48.87%
47.37%
49.48%
44.38%
PAT Margin
16.62%
31.57%
21.69%
38.0%
36.14%
33.25%
27.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -0.53% vs 14.18% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -22.92% vs 76.83% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 46.16% vs -19.60% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 19.27% vs 14.74% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Natco Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
735.20
840.80
-105.60
-12.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
735.20
840.80
-105.60
-12.56%
Raw Material Cost
157.80
220.67
-62.87
-28.49%
Purchase of Finished goods
27.80
138.45
-110.65
-79.92%
(Increase) / Decrease In Stocks
-38.10
-15.65
-22.45
-143.45%
Employee Cost
179.30
114.29
65.01
56.88%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
221.90
170.01
51.89
30.52%
Total Expenditure (Excl Depreciation)
548.70
627.77
-79.07
-12.60%
Operating Profit (PBDIT) excl Other Income
186.50
213.03
-26.53
-12.45%
Other Income
59.20
25.40
33.80
133.07%
Operating Profit (PBDIT)
245.70
238.43
7.27
3.05%
Interest
13.00
7.00
6.00
85.71%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
232.70
231.43
1.27
0.55%
Depreciation
47.10
24.86
22.24
89.46%
Profit Before Tax
185.60
206.57
-20.97
-10.15%
Tax
63.40
47.16
16.24
34.44%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
122.20
159.41
-37.21
-23.34%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
122.20
159.41
-37.21
-23.34%
Share in Profit of Associates
84.30
0.00
84.30
Minority Interest
0.00
2.24
-2.24
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
206.50
157.17
49.33
31.39%
Equity Capital
35.80
45.32
-9.52
-21.01%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
11.54
3.47
8.07
232.56%
Diluted Earnings per share
11.53
3.47
8.06
232.28%
Operating Profit Margin (Excl OI)
25.37%
25.34%
0.00
0.03%
Gross Profit Margin
31.65%
27.52%
0.00
4.13%
PAT Margin
16.62%
18.96%
0.00
-2.34%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 735.20 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -0.53% vs 14.18% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -44.68% vs -2.47% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 206.50 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -22.92% vs 76.83% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -57.04% vs -28.09% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 186.50 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 46.16% vs -19.60% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -67.34% vs -29.05% in Jun 2025

Quarterly - Interest
Interest 13.00 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 19.27% vs 14.74% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 306.25% vs -38.46% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.37%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Footer loading